Clinical Outcomes with Biosimilars: Do They Work as Well as the Original Biologics?
Dec 26 2025
Multiple System Atrophy: Understanding Parkinsonian Features and Poor Prognosis
Multiple System Atrophy (MSA-P) is a rare, aggressive neurological disorder with parkinsonian symptoms and severe autonomic failure. Unlike Parkinson’s, it progresses rapidly, responds poorly to treatment, and has a median survival of only 6-10 years.
